Summary

The research team projects that the Veterinary mRNA Vaccines market size will grow from XXX in 2025 to XXX by 2030, at an estimated CAGR of XX. The base year considered for the study is 2024, and the market size is projected from 2025 to 2030.

The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing with 10 major regions and 50 major countries. Deep researches and analysis were done during the preparation of the report. The readers will find this report very helpful in understanding the market in depth. The data and the information regarding the market are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the industry experts. The facts and data are represented in the report using diagrams, graphs, pie charts, and other pictorial representations. This enhances the visual representation and also helps in understanding the facts much better.

By Market Players:
Ceva Animal Health
Merck Animal Health
Areterna
Bayer
BioNTech
Genvax Technologies
BioVenic
Moderna
Ruipu Biotechnology
Jinyu Bio-technology
Shanghai Shen Lian Biomedical
Suzhou Kerui Meide Biomedical Technology
Shanghai Rnacure Biopharma

By Type
Injectable Drug Administration
Non-invasive Drug Administration

By Application
for Poultry
for Livestock
Others

By Regions/Countries:
North America
United States
Canada
Mexico

East Asia
China
Japan
South Korea

Europe
Germany
United Kingdom
France
Italy
Russia
Spain
Netherlands
Switzerland
Poland

South Asia
India
Pakistan
Bangladesh

Southeast Asia
Indonesia
Thailand
Singapore
Malaysia
Philippines
Vietnam
Myanmar

Middle East
Turkey
Saudi Arabia
Iran
United Arab Emirates
Israel
Iraq
Qatar
Kuwait
Oman

Africa
Nigeria
South Africa
Egypt
Algeria
Morocoo

Oceania
Australia
New Zealand

South America
Brazil
Argentina
Colombia
Chile
Venezuela
Peru
Puerto Rico
Ecuador

Rest of the World
Kazakhstan

Points Covered in The Report
The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.
The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.
Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.
The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.

Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.

The report focuses on Global, Top 10 Regions and Top 50 Countries Market Size of Veterinary mRNA Vaccines 2019-2024, and development forecast 2025-2030 including industries, major players/suppliers worldwide and market share by regions, with company and product introduction, position in the market including their market status and development trend by types and applications which will provide its price and profit status, and marketing status & market growth drivers and challenges, with base year as 2020.

Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2019-2024 & Sales by Product Types.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2025-2030. Further the report provides break down details about each region & countries covered in the report. Identifying its production, consumption, import & export, sales volume & revenue forecast.
Market Analysis by Product Type: The report covers majority Product Types in the Veterinary mRNA Vaccines Industry, including its product specifcations by each key player, volume, sales by Volume and Value (M USD).
Markat Analysis by Application Type: Based on the Veterinary mRNA Vaccines Industry and its applications, the market is further sub-segmented into several major Application of its industry. It provides you with the market size, CAGR & forecast by each industry applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report will provide with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

COVID-19 Impact
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Veterinary mRNA Vaccines market in 2024. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

ページTOPに戻る

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Veterinary mRNA Vaccines Revenue
1.4 Market Analysis by Type
1.4.1 Global Veterinary mRNA Vaccines Market Size Growth Rate by Type: 2025 VS 2030
1.4.2 Injectable Drug Administration
1.4.3 Non-invasive Drug Administration
1.5 Market by Application
1.5.1 Global Veterinary mRNA Vaccines Market Share by Application: 2025-2030
1.5.2 for Poultry
1.5.3 for Livestock
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Veterinary mRNA Vaccines Market
1.8.1 Global Veterinary mRNA Vaccines Market Status and Outlook (2019-2030)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
1.9 Global Market Growth Prospects
1.9.1 Global Veterinary mRNA Vaccines Revenue Estimates and Forecasts (2019-2030)
1.9.2 Global Veterinary mRNA Vaccines Production Capacity Estimates and Forecasts (2019-2030)
1.9.3 Global Veterinary mRNA Vaccines Production Estimates and Forecasts (2019-2030)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material
2.2 Manufacturing Cost Structure Analysis of Veterinary mRNA Vaccines
2.3 Manufacturing Process Analysis of Veterinary mRNA Vaccines
2.4 Industry Chain Structure of Veterinary mRNA Vaccines
3 Development and Manufacturing Plants Analysis of Veterinary mRNA Vaccines
3.1 Top Manufacturers Headquarters, Rank by Veterinary mRNA Vaccines Production
3.2 Global Veterinary mRNA Vaccines Manufacturing Plants Distribution and Commercial Production Date
4 Market Competition by Manufacturers
4.1 Global Veterinary mRNA Vaccines Production Capacity Market Share by Manufacturers (2019-2024)
4.2 Global Veterinary mRNA Vaccines Revenue Market Share by Manufacturers (2019-2024)
4.3 Global Veterinary mRNA Vaccines Average Price by Manufacturers (2019-2024)
4.4 Manufacturers Veterinary mRNA Vaccines Production Sites, Area Served, Product Type
5 Veterinary mRNA Vaccines Regional Market Analysis
5.1 Veterinary mRNA Vaccines Production by Regions
5.1.1 Global Veterinary mRNA Vaccines Production by Regions (2019-2024)
5.1.2 Global Veterinary mRNA Vaccines Revenue by Regions
5.2 Veterinary mRNA Vaccines Consumption by Regions
5.3 North America Veterinary mRNA Vaccines Market Analysis
5.3.1 North America Veterinary mRNA Vaccines Production
5.3.2 North America Veterinary mRNA Vaccines Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Veterinary mRNA Vaccines Import and Export
5.4 East Asia Veterinary mRNA Vaccines Market Analysis
5.4.1 East Asia Veterinary mRNA Vaccines Production
5.4.2 East Asia Veterinary mRNA Vaccines Revenue
5.4.3 Key Manufacturers in East Asia
5.4.4 East Asia Veterinary mRNA Vaccines Import & Export
5.5 Europe Veterinary mRNA Vaccines Market Analysis
5.5.1 Europe Veterinary mRNA Vaccines Production
5.5.2 Europe Veterinary mRNA Vaccines Revenue
5.5.3 Key Manufacturers in Europe
5.5.4 Europe Veterinary mRNA Vaccines Import & Export
5.6 South Asia Veterinary mRNA Vaccines Market Analysis
5.6.1 South Asia Veterinary mRNA Vaccines Production
5.6.2 South Asia Veterinary mRNA Vaccines Revenue
5.6.3 Key Manufacturers in South Asia
5.6.4 South Asia Veterinary mRNA Vaccines Import & Export
5.7 Southeast Asia Veterinary mRNA Vaccines Market Analysis
5.7.1 Southeast Asia Veterinary mRNA Vaccines Production
5.7.2 Southeast Asia Veterinary mRNA Vaccines Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Veterinary mRNA Vaccines Import & Export
5.8 Middle East Veterinary mRNA Vaccines Market Analysis
5.8.1 Middle East Veterinary mRNA Vaccines Production
5.8.2 Middle East Veterinary mRNA Vaccines Revenue
5.8.3 Key Manufacturers in Middle East
5.8.4 Middle East Veterinary mRNA Vaccines Import & Export
5.9 Africa Veterinary mRNA Vaccines Market Analysis
5.9.1 Africa Veterinary mRNA Vaccines Production
5.9.2 Africa Veterinary mRNA Vaccines Revenue
5.9.3 Key Manufacturers in Africa
5.9.4 Africa Veterinary mRNA Vaccines Import & Export
5.10 Oceania Veterinary mRNA Vaccines Market Analysis
5.10.1 Oceania Veterinary mRNA Vaccines Production
5.10.2 Oceania Veterinary mRNA Vaccines Revenue
5.10.3 Key Manufacturers in Oceania
5.10.4 Oceania Veterinary mRNA Vaccines Import & Export
5.11 South America Veterinary mRNA Vaccines Market Analysis
5.11.1 South America Veterinary mRNA Vaccines Production
5.11.2 South America Veterinary mRNA Vaccines Revenue
5.11.3 Key Manufacturers in South America
5.11.4 South America Veterinary mRNA Vaccines Import & Export
6 Veterinary mRNA Vaccines Sales Market by Type (2019-2030)
6.1 Global Veterinary mRNA Vaccines Historic Market Size by Type (2019-2024)
6.2 Global Veterinary mRNA Vaccines Forecasted Market Size by Type (2025-2030)
7 Veterinary mRNA Vaccines Consumption Market by Application(2019-2030)
7.1 Global Veterinary mRNA Vaccines Historic Market Size by Application (2019-2024)
7.2 Global Veterinary mRNA Vaccines Forecasted Market Size by Application (2025-2030)
8 Company Profiles and Key Figures in Veterinary mRNA Vaccines Business
8.1 Ceva Animal Health
8.1.1 Ceva Animal Health Company Profile
8.1.2 Ceva Animal Health Veterinary mRNA Vaccines Product Specification
8.1.3 Ceva Animal Health Veterinary mRNA Vaccines Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.2 Merck Animal Health
8.2.1 Merck Animal Health Company Profile
8.2.2 Merck Animal Health Veterinary mRNA Vaccines Product Specification
8.2.3 Merck Animal Health Veterinary mRNA Vaccines Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.3 Areterna
8.3.1 Areterna Company Profile
8.3.2 Areterna Veterinary mRNA Vaccines Product Specification
8.3.3 Areterna Veterinary mRNA Vaccines Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.4 Bayer
8.4.1 Bayer Company Profile
8.4.2 Bayer Veterinary mRNA Vaccines Product Specification
8.4.3 Bayer Veterinary mRNA Vaccines Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.5 BioNTech
8.5.1 BioNTech Company Profile
8.5.2 BioNTech Veterinary mRNA Vaccines Product Specification
8.5.3 BioNTech Veterinary mRNA Vaccines Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.6 Genvax Technologies
8.6.1 Genvax Technologies Company Profile
8.6.2 Genvax Technologies Veterinary mRNA Vaccines Product Specification
8.6.3 Genvax Technologies Veterinary mRNA Vaccines Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.7 BioVenic
8.7.1 BioVenic Company Profile
8.7.2 BioVenic Veterinary mRNA Vaccines Product Specification
8.7.3 BioVenic Veterinary mRNA Vaccines Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.8 Moderna
8.8.1 Moderna Company Profile
8.8.2 Moderna Veterinary mRNA Vaccines Product Specification
8.8.3 Moderna Veterinary mRNA Vaccines Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.9 Ruipu Biotechnology
8.9.1 Ruipu Biotechnology Company Profile
8.9.2 Ruipu Biotechnology Veterinary mRNA Vaccines Product Specification
8.9.3 Ruipu Biotechnology Veterinary mRNA Vaccines Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.10 Jinyu Bio-technology
8.10.1 Jinyu Bio-technology Company Profile
8.10.2 Jinyu Bio-technology Veterinary mRNA Vaccines Product Specification
8.10.3 Jinyu Bio-technology Veterinary mRNA Vaccines Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.11 Shanghai Shen Lian Biomedical
8.11.1 Shanghai Shen Lian Biomedical Company Profile
8.11.2 Shanghai Shen Lian Biomedical Veterinary mRNA Vaccines Product Specification
8.11.3 Shanghai Shen Lian Biomedical Veterinary mRNA Vaccines Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.12 Suzhou Kerui Meide Biomedical Technology
8.12.1 Suzhou Kerui Meide Biomedical Technology Company Profile
8.12.2 Suzhou Kerui Meide Biomedical Technology Veterinary mRNA Vaccines Product Specification
8.12.3 Suzhou Kerui Meide Biomedical Technology Veterinary mRNA Vaccines Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.13 Shanghai Rnacure Biopharma
8.13.1 Shanghai Rnacure Biopharma Company Profile
8.13.2 Shanghai Rnacure Biopharma Veterinary mRNA Vaccines Product Specification
8.13.3 Shanghai Rnacure Biopharma Veterinary mRNA Vaccines Production Capacity, Revenue, Price and Gross Margin (2019-2024)
9 Production and Supply Forecast
9.1 Global Forecasted Production of Veterinary mRNA Vaccines (2025-2030)
9.2 Global Forecasted Revenue of Veterinary mRNA Vaccines (2025-2030)
9.3 Global Forecasted Price of Veterinary mRNA Vaccines (2019-2030)
9.4 Global Forecasted Production of Veterinary mRNA Vaccines by Region (2025-2030)
9.4.1 North America Veterinary mRNA Vaccines Production, Revenue Forecast (2025-2030)
9.4.2 East Asia Veterinary mRNA Vaccines Production, Revenue Forecast (2025-2030)
9.4.3 Europe Veterinary mRNA Vaccines Production, Revenue Forecast (2025-2030)
9.4.4 South Asia Veterinary mRNA Vaccines Production, Revenue Forecast (2025-2030)
9.4.5 Southeast Asia Veterinary mRNA Vaccines Production, Revenue Forecast (2025-2030)
9.4.6 Middle East Veterinary mRNA Vaccines Production, Revenue Forecast (2025-2030)
9.4.7 Africa Veterinary mRNA Vaccines Production, Revenue Forecast (2025-2030)
9.4.8 Oceania Veterinary mRNA Vaccines Production, Revenue Forecast (2025-2030)
9.4.9 South America Veterinary mRNA Vaccines Production, Revenue Forecast (2025-2030)
9.4.10 Rest of the World Veterinary mRNA Vaccines Production, Revenue Forecast (2025-2030)
9.5 Forecast by Type and by Application (2025-2030)
9.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2025-2030)
9.5.2 Global Forecasted Consumption of Veterinary mRNA Vaccines by Application (2025-2030)
10 Consumption and Demand Forecast
10.1 North America Forecasted Consumption of Veterinary mRNA Vaccines by Country
10.2 East Asia Market Forecasted Consumption of Veterinary mRNA Vaccines by Country
10.3 Europe Market Forecasted Consumption of Veterinary mRNA Vaccines by Countriy
10.4 South Asia Forecasted Consumption of Veterinary mRNA Vaccines by Country
10.5 Southeast Asia Forecasted Consumption of Veterinary mRNA Vaccines by Country
10.6 Middle East Forecasted Consumption of Veterinary mRNA Vaccines by Country
10.7 Africa Forecasted Consumption of Veterinary mRNA Vaccines by Country
10.8 Oceania Forecasted Consumption of Veterinary mRNA Vaccines by Country
10.9 South America Forecasted Consumption of Veterinary mRNA Vaccines by Country
10.10 Rest of the world Forecasted Consumption of Veterinary mRNA Vaccines by Country
11 Marketing Channel, Distributors and Customers
11.1 Marketing Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
12 Market Dynamics
12.1 Market Trends
12.2 Opportunities and Drivers
12.3 Challenges
12.4 Porter's Five Forces Analysis
13 Conclusion
14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer